当前位置:首页 >财报库 > 报告详情

嘉德诺Cardinal Health(CAH) 2024财年10-K年度报告「NYSE」(英文版)(139页).pdf

上传人: Kell****reet 编号:653870 2025-05-20 139页 1.65MB

下载:

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-KANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended June 30,2024orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1

2、934For the transition period from _ to _Commission File Number:1-11373Cardinal Health,Inc.(Exact name of registrant as specified in its charter)Ohio31-0958666(State or other jurisdiction ofincorporation or organization)(IRS EmployerIdentification No.)7000 Cardinal PlaceDublin,Ohio43017(Address of pr

3、incipal executive offices)(Zip Code)(614)757-5000(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon shares(without par value)CAHNew York Stock ExchangeSecuriti

4、es registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No oIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the A

5、ct.Yes o No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 duringthe preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject t

6、o such filing requirements forthe past 90 days.Yes No oIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter peri

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文是Cardinal Health公司的2024财年报告,主要内容包括: 1. 公司概况:Cardinal Health是一家全球性的医疗保健服务和产品公司,提供定制化的医院、医疗系统、药房、门诊手术中心、临床实验室、医生办公室和患者在家中的解决方案。 2. 财务数据:2024财年,公司总收入为2268.27亿美元,同比增长11%;净利润为12.43亿美元,同比增长65%。2023财年,总收入为2049.79亿美元,同比增长13%;净利润为7.52亿美元,同比增长16%。 3. 业务板块:公司分为两个报告部门:药品和特种解决方案部门以及全球医疗产品和分销部门。 4. 重大事件:2024年3月,公司完成了对Specialty Networks的12亿美元现金收购。2024年4月,公司宣布与OptumRx的药品分销合同将于2024年6月到期。 5. 风险因素:公司面临的主要风险包括药品供应短缺、通货膨胀、诉讼风险等。 6. 未来展望:公司预计2025财年的资本支出将在5亿美元至5.5亿美元之间,主要用于制造和分销基础设施项目和科技投资。
财务报表中的会计错误是什么? 会计错误对先前季度或年度财务报表的影响是什么? 会计错误是如何被识别和纠正的?
客服
商务合作
小程序
服务号
折叠